Literature DB >> 16735955

Testing for sexually transmitted diseases in U.S. Public health laboratories in 2004.

Linda Webster Dicker1, Debra J Mosure, Richard Steece, Katherine M Stone.   

Abstract

OBJECTIVE: Appropriate laboratory testing practices are a critical part of sexually transmitted disease (STD) control. GOAL: The goal of this study was to describe the type and volume of STD tests performed in public health laboratories in the United States in 2004. STUDY
DESIGN: A web-based survey was made available to 144 members of the Association of Public Health Laboratories.
RESULTS: One hundred fourteen laboratories responded (79%). Overall, 3,553,196 chlamydia tests and 3,461,151 gonorrhea tests were performed; 64.4% of chlamydia tests and 60.8% of gonorrhea tests were nucleic acid amplification tests. Ninety-four percent of laboratories performed syphilis testing. Few laboratories used type-specific tests for herpes simplex virus or used new tests for trichomoniasis, bacterial vaginosis, or human papillomavirus.
CONCLUSIONS: This survey collected important data that can be used to monitor trends in STD testing practices in public health laboratories.

Entities:  

Mesh:

Year:  2007        PMID: 16735955     DOI: 10.1097/01.olq.0000222708.70594.8e

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  11 in total

1.  An electrochemical scaffold sensor for rapid syphilis diagnosis.

Authors:  Nathan E Ogden; Martin Kurnik; Claudio Parolo; Kevin W Plaxco
Journal:  Analyst       Date:  2019-08-16       Impact factor: 4.616

2.  Chlamydia positivity trends among women attending family planning clinics: United States, 2004-2008.

Authors:  Catherine Lindsey Satterwhite; LaZetta Grier; Rachel Patzer; Hillard Weinstock; Penelope P Howards; David Kleinbaum
Journal:  Sex Transm Dis       Date:  2011-11       Impact factor: 2.830

3.  Is there evidence of the new variant Chlamydia trachomatis in the United States?

Authors:  Helen Won; Padmini Ramachandran; Richard Steece; Barbara Van Der Pol; Jeanne Moncada; Julius Schachter; Charlotte Gaydos
Journal:  Sex Transm Dis       Date:  2013-05       Impact factor: 2.830

Review 4.  The use of cephalosporins for gonorrhea: the impending problem of resistance.

Authors:  Pennan M Barry; Jeffrey D Klausner
Journal:  Expert Opin Pharmacother       Date:  2009-03       Impact factor: 3.889

5.  Evaluation of CDC-recommended approaches for confirmatory testing of positive Neisseria gonorrhoeae nucleic acid amplification test results.

Authors:  Jeanne Moncada; Elizabeth Donegan; Julius Schachter
Journal:  J Clin Microbiol       Date:  2008-03-05       Impact factor: 5.948

6.  Molecular Diagnosis of Sexually Transmitted Chlamydia trachomatis in the United States.

Authors:  April L Harkins; Erik Munson
Journal:  ISRN Obstet Gynecol       Date:  2011-06-12

7.  Lymphogranuloma venereum: old pathogen, new story.

Authors:  Preeti Pathela; Susan Blank; Julia A Schillinger
Journal:  Curr Infect Dis Rep       Date:  2007-03       Impact factor: 3.663

Review 8.  Molecular diagnostics for gonorrhoea: implications for antimicrobial resistance and the threat of untreatable gonorrhoea.

Authors:  Nicola Low; Magnus Unemo; Jørgen Skov Jensen; Judith Breuer; Judith M Stephenson
Journal:  PLoS Med       Date:  2014-02-04       Impact factor: 11.069

9.  Accurate detection of Neisseria gonorrhoeae ciprofloxacin susceptibility directly from genital and extragenital clinical samples: towards genotype-guided antimicrobial therapy.

Authors:  Marcus J Pond; Catherine L Hall; Victoria F Miari; Michelle Cole; Ken G Laing; Heena Jagatia; Emma Harding-Esch; Irene M Monahan; Timothy Planche; Jason Hinds; Catherine A Ison; Stephanie Chisholm; Philip D Butcher; Syed Tariq Sadiq
Journal:  J Antimicrob Chemother       Date:  2016-01-26       Impact factor: 5.790

10.  Recommendations for Providing Quality Sexually Transmitted Diseases Clinical Services, 2020.

Authors:  Roxanne Y Barrow; Faruque Ahmed; Gail A Bolan; Kimberly A Workowski
Journal:  MMWR Recomm Rep       Date:  2020-01-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.